Fulcrum Capital LLC Buys 4,141 Shares of CVS Health Corp (CVS)  Dante Gardener | Aug 17th, 2018
Fulcrum Capital LLC increased its stake in shares of CVS Health Corp (NYSE:CVS) by 7.7% in the second quarter, HoldingsChannel reports. The firm owned 58,113 shares of the pharmacy operator's stock after buying an additional 4,141 shares during the quarter. CVS Health makes up approximately 1.8% of Fulcrum Capital LLC's holdings, making the stock its 25th biggest holding. Fulcrum Capital LLC's holdings in CVS Health were worth $3,740,000 at the end of the most recent quarter.
A number of other institutional investors also recently bought and sold shares of CVS. Adviser Investments LLC grew its holdings in CVS Health by 43.3% in the 2nd quarter. Adviser Investments LLC now owns 2,993 shares of the pharmacy operator's stock valued at $193,000 after buying an additional 905 shares during the period. BancorpSouth Bank purchased a new stake in CVS Health in the 4th quarter valued at about $2,389,000. Whitnell & Co. grew its holdings in CVS Health by 3.6% in the 2nd quarter. Whitnell & Co. now owns 50,248 shares of the pharmacy operator's stock valued at $3,233,000 after buying an additional 1,725 shares during the period. ICM Asset Management Inc. WA purchased a new stake in CVS Health in the 2nd quarter valued at about $1,152,000. Finally, Chase Investment Counsel Corp purchased a new stake in CVS Health in the 1st quarter valued at about $235,000. Hedge funds and other institutional investors own 83.60% of the company's stock. Get CVS Health alerts:
Shares of NYSE:CVS opened at $73.20 on Friday. The company has a debt-to-equity ratio of 1.73, a current ratio of 2.34 and a quick ratio of 1.87. CVS Health Corp has a 1 year low of $60.14 and a 1 year high of $84.00. The stock has a market cap of $70.30 billion, a PE ratio of 12.41, a PEG ratio of 0.93 and a beta of 0.96.
CVS Health (NYSE:CVS) last issued its earnings results on Wednesday, August 8th. The pharmacy operator reported $1.69 earnings per share (EPS) for the quarter, topping the Zacks' consensus estimate of $1.61 by $0.08. CVS Health had a return on equity of 18.25% and a net margin of 1.61%. The business had revenue of $46.71 billion during the quarter, compared to analysts' expectations of $46.34 billion. During the same quarter in the previous year, the business earned $1.33 EPS. The company's revenue for the quarter was up 2.2% on a year-over-year basis. sell-side analysts forecast that CVS Health Corp will post 7.04 EPS for the current year.
The company also recently announced a quarterly dividend, which was paid on Wednesday, August 1st. Stockholders of record on Wednesday, July 25th were issued a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.73%. The ex-dividend date of this dividend was Tuesday, July 24th. CVS Health's payout ratio is currently 33.90%.
Several research firms have commented on CVS. Leerink Swann set a $80.00 price target on CVS Health and gave the company an "outperform" rating in a report on Thursday, August 9th. Royal Bank of Canada restated a "buy" rating and issued a $90.00 price target on shares of CVS Health in a report on Wednesday, August 8th. Citigroup restated a "buy" rating and issued a $81.00 price target on shares of CVS Health in a report on Monday, July 9th. Morgan Stanley lowered their price target on CVS Health from $88.00 to $80.00 and set an "overweight" rating for the company in a report on Tuesday, July 3rd. Finally, Mizuho restated a "buy" rating on shares of CVS Health in a report on Saturday, June 30th. Three investment analysts have rated the stock with a sell rating, four have given a hold rating, eleven have issued a buy rating and two have issued a strong buy rating to the company. The stock has a consensus rating of "Buy" and a consensus price target of $86.04.
CVS Health Profile
CVS Health Corporation, together with its subsidiaries, provides integrated pharmacy health care services. It operates through Pharmacy Services and Retail/LTC segments. The Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, Medicare Part D services, mail order, specialty pharmacy and infusion services, retail pharmacy network management services, prescription management systems, clinical services, disease management programs, and medical pharmacy management services.
Further Reading: Asset Allocation and Your Retirement
Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corp (NYSE:CVS). CVS Health CVS Healt